HOMEPRODUCTSSERVICESCOMPANYCONTACTFAQResearchDictionaryPharmaMobileSign Up FREE or Login

BMS 540215

has antineoplastic activity; structure in first source
Also Known As:
BMS-540215; BMS540215; brivanib
Networked: 31 relevant articles (5 outcomes, 19 trials/studies)

Relationship Network

Bio-Agent Context: Research Results

Experts

1. Walters, Ian: 8 articles (10/2014 - 04/2011)
2. Finn, Richard S: 5 articles (11/2014 - 04/2011)
3. Park, Joong-Won: 5 articles (10/2014 - 04/2011)
4. Kudo, Masatoshi: 4 articles (11/2014 - 01/2011)
5. Raoul, Jean-Luc: 4 articles (10/2014 - 04/2011)
6. Fargnoli, Joseph: 4 articles (02/2010 - 04/2006)
7. Decaens, Thomas: 3 articles (10/2015 - 10/2013)
8. Han, Guohong: 3 articles (11/2014 - 03/2014)
9. Tak, Won-Young: 3 articles (11/2014 - 10/2013)
10. Baudelet, Christine: 3 articles (10/2014 - 04/2011)

Related Diseases

1. Hepatocellular Carcinoma (Hepatoma)
2. Neoplasms (Cancer)
3. Hypotension (Low Blood Pressure)
4. Portal Hypertension
5. Ascites

Related Drugs and Biologics

1. sorafenib (BAY 43-9006)
2. Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)
3. BMS 582664
4. Fibroblast Growth Factors (Fibroblast Growth Factor)
5. Nitric Oxide (Nitrogen Monoxide)
6. Mannitol (Osmitrol)
7. Aldosterone
8. cetuximab (Erbitux)
9. Fibroblast Growth Factor Receptors (Fibroblast Growth Factor Receptor)
10. Epirubicin (Ellence)

Related Therapies and Procedures

1. Heterologous Transplantation (Xenotransplantation)
2. Combination Drug Therapy (Combination Chemotherapy)
3. Drug Therapy (Chemotherapy)